Ten new cytotoxic drugs have been added to the interaction charts - dasatinib, erlotinib, everolimus, gefitinib, lapatinib, nilotinib, pazopanib, sorafenib, sunitinib and temsirolimus.
The printable charts have been updated and now include interactions with elvitegravir/cobicistat and these new comedications.
